JP Stock MarketDetailed Quotes

8141 Shinko Shoji

Watchlist

950
+22+2.37%

20min DelayMarket Closed Dec 16 15:30 JST

36.11BMarket Cap9.84P/E (Static)

Shinko Shoji Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Jun 30, 2024

(FY)Mar 31, 2024

(Q4)Mar 31, 2024

(Q3)Dec 31, 2023

(Q2)Sep 30, 2023

(Q1)Jun 30, 2023

(FY)Mar 31, 2023

(Q4)Mar 31, 2023

(Q3)Dec 31, 2022

(Q2)Sep 30, 2022

Total revenue

-28.30%32.57B

-1.80%175.85B

-7.11%42.64B

-9.48%39.58B

0.22%48.2B

9.85%45.43B

32.45%179.08B

6.32%45.9B

30.74%43.73B

70.34%48.09B

Cost of revenue

-28.44%29.53B

-0.57%161.14B

-2.61%40.24B

-9.16%35.69B

0.04%43.95B

9.94%41.26B

32.53%162.07B

7.47%41.32B

28.93%39.29B

70.67%43.94B

Gross profit

-26.97%3.05B

-13.53%14.7B

-47.65%2.4B

-12.38%3.89B

2.19%4.24B

8.96%4.17B

31.69%17B

-3.00%4.59B

49.38%4.44B

66.92%4.15B

Operating expense

-5.82%2.3B

-0.51%9.82B

-12.34%2.4B

2.88%2.4B

2.29%2.59B

7.16%2.44B

12.86%9.87B

6.17%2.74B

11.54%2.33B

24.96%2.53B

Operating profit

-56.82%747M

-31.56%4.88B

-99.95%1M

-29.25%1.49B

2.03%1.66B

11.61%1.73B

71.25%7.13B

-14.01%1.85B

139.05%2.11B

249.46%1.63B

Net non-operating interest income (expenses)

150.00%16M

35.29%-88M

103.13%1M

51.16%-21M

2.70%-36M

-33.33%-32M

-353.33%-136M

-88.24%-32M

-760.00%-43M

-1,133.33%-37M

Non-operating interest income

363.64%51M

591.67%83M

471.43%40M

--20M

300.00%12M

450.00%11M

-52.00%12M

16.67%7M

--0

-62.50%3M

Non-operating interest expense

-18.60%35M

15.54%171M

0.00%39M

-4.65%41M

20.00%48M

65.38%43M

169.09%148M

69.57%39M

330.00%43M

263.64%40M

Net investment income

2,088.89%179M

92.09%-11M

147.24%60M

55.64%-114M

-71.11%52M

-113.85%-9M

-152.73%-139M

-202.38%-127M

-2,755.56%-257M

373.68%180M

Gain(Loss) on financial instruments designated as cash flow hedges

Gain(Loss) on derecognition of available-for-sale financial assets

83M

Income from associates and other participating interests

Special income (charges)

-6,940.00%-352M

-562.50%-185M

-12,750.00%-253M

73.68%66M

-5M

4,100.00%40M

38M

Less:Other special charges

6,940.00%352M

562.50%185M

12,750.00%253M

---7M

---66M

--5M

-4,100.00%-40M

---2M

--0

----

Other non-operating income (expenses)

-15.38%11M

8.33%-11M

22.41%-45M

375.00%11M

-62.96%10M

-43.48%13M

-148.00%-12M

14.71%-58M

-105.80%-4M

27M

Income before tax

-64.60%600M

-32.19%4.67B

-114.51%-237M

-23.86%1.37B

0.22%1.84B

5.02%1.7B

66.41%6.88B

-19.16%1.63B

92.32%1.8B

261.34%1.83B

Income tax

-53.92%270M

-32.36%1.39B

-159.28%-230M

-24.21%407M

5.03%627M

9.94%586M

62.97%2.06B

-36.18%388M

82.03%537M

273.13%597M

Net income

-70.24%330M

-32.12%3.28B

-100.56%-7M

-23.85%964M

-2.03%1.21B

2.59%1.11B

67.88%4.83B

-11.90%1.24B

97.20%1.27B

255.62%1.23B

Net income continuous operations

-70.24%330M

-32.12%3.28B

-100.56%-7M

-23.72%965M

-2.11%1.21B

2.59%1.11B

67.92%4.83B

-11.83%1.25B

97.04%1.27B

255.91%1.24B

Noncontrolling interests

-68.00%8M

-32.77%80M

-64.52%11M

-51.28%19M

13.64%25M

-7.41%25M

124.53%119M

93.75%31M

116.67%39M

120.00%22M

Net income attributable to the company

-70.36%321M

-32.13%3.19B

-101.48%-18M

-22.98%945M

-2.31%1.18B

2.75%1.08B

66.82%4.71B

-13.17%1.21B

96.63%1.23B

260.71%1.21B

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

-70.36%321M

-32.13%3.19B

-101.48%-18M

-22.98%945M

-2.31%1.18B

2.75%1.08B

66.82%4.71B

-13.17%1.21B

96.63%1.23B

260.71%1.21B

Gross dividend payment

Basic earnings per share

-70.30%9.73

-29.93%96.53

-101.51%-0.55

-21.52%28.55

1.02%35.77

10.98%32.76

81.01%137.77

-3.39%36.46

116.42%36.38

291.27%35.41

Diluted earnings per share

-70.30%9.73

-29.93%96.53

-101.51%-0.55

-21.53%28.5467

1.01%35.7688

10.98%32.76

81.01%137.77

-3.39%36.46

116.56%36.38

291.27%35.41

Dividend per share

-29.71%48.5

-45.00%22

-8.62%26.5

15.97%69

9.59%40

26.09%29

Currency Unit

JPY

Accounting Standards

NonUS-GAAP

	(Q1)Jun 30, 2024	(FY)Mar 31, 2024	(Q4)Mar 31, 2024	(Q3)Dec 31, 2023	(Q2)Sep 30, 2023	(Q1)Jun 30, 2023	(FY)Mar 31, 2023	(Q4)Mar 31, 2023	(Q3)Dec 31, 2022	(Q2)Sep 30, 2022
Total revenue	-28.30%32.57B	-1.80%175.85B	-7.11%42.64B	-9.48%39.58B	0.22%48.2B	9.85%45.43B	32.45%179.08B	6.32%45.9B	30.74%43.73B	70.34%48.09B
Cost of revenue	-28.44%29.53B	-0.57%161.14B	-2.61%40.24B	-9.16%35.69B	0.04%43.95B	9.94%41.26B	32.53%162.07B	7.47%41.32B	28.93%39.29B	70.67%43.94B
Gross profit	-26.97%3.05B	-13.53%14.7B	-47.65%2.4B	-12.38%3.89B	2.19%4.24B	8.96%4.17B	31.69%17B	-3.00%4.59B	49.38%4.44B	66.92%4.15B
Operating expense	-5.82%2.3B	-0.51%9.82B	-12.34%2.4B	2.88%2.4B	2.29%2.59B	7.16%2.44B	12.86%9.87B	6.17%2.74B	11.54%2.33B	24.96%2.53B
Operating profit	-56.82%747M	-31.56%4.88B	-99.95%1M	-29.25%1.49B	2.03%1.66B	11.61%1.73B	71.25%7.13B	-14.01%1.85B	139.05%2.11B	249.46%1.63B
Net non-operating interest income (expenses)	150.00%16M	35.29%-88M	103.13%1M	51.16%-21M	2.70%-36M	-33.33%-32M	-353.33%-136M	-88.24%-32M	-760.00%-43M	-1,133.33%-37M
Non-operating interest income	363.64%51M	591.67%83M	471.43%40M	--20M	300.00%12M	450.00%11M	-52.00%12M	16.67%7M	--0	-62.50%3M
Non-operating interest expense	-18.60%35M	15.54%171M	0.00%39M	-4.65%41M	20.00%48M	65.38%43M	169.09%148M	69.57%39M	330.00%43M	263.64%40M
Net investment income	2,088.89%179M	92.09%-11M	147.24%60M	55.64%-114M	-71.11%52M	-113.85%-9M	-152.73%-139M	-202.38%-127M	-2,755.56%-257M	373.68%180M
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets	0	83M	0	0	83M	0	0	0	0	0
Income from associates and other participating interests
Special income (charges)	-6,940.00%-352M	-562.50%-185M	-12,750.00%-253M	7M	73.68%66M	-5M	4,100.00%40M	2M	0	38M
Less:Other special charges	6,940.00%352M	562.50%185M	12,750.00%253M	---7M	---66M	--5M	-4,100.00%-40M	---2M	--0	----
Other non-operating income (expenses)	-15.38%11M	8.33%-11M	22.41%-45M	375.00%11M	-62.96%10M	-43.48%13M	-148.00%-12M	14.71%-58M	-105.80%-4M	27M
Income before tax	-64.60%600M	-32.19%4.67B	-114.51%-237M	-23.86%1.37B	0.22%1.84B	5.02%1.7B	66.41%6.88B	-19.16%1.63B	92.32%1.8B	261.34%1.83B
Income tax	-53.92%270M	-32.36%1.39B	-159.28%-230M	-24.21%407M	5.03%627M	9.94%586M	62.97%2.06B	-36.18%388M	82.03%537M	273.13%597M
Net income	-70.24%330M	-32.12%3.28B	-100.56%-7M	-23.85%964M	-2.03%1.21B	2.59%1.11B	67.88%4.83B	-11.90%1.24B	97.20%1.27B	255.62%1.23B
Net income continuous operations	-70.24%330M	-32.12%3.28B	-100.56%-7M	-23.72%965M	-2.11%1.21B	2.59%1.11B	67.92%4.83B	-11.83%1.25B	97.04%1.27B	255.91%1.24B
Noncontrolling interests	-68.00%8M	-32.77%80M	-64.52%11M	-51.28%19M	13.64%25M	-7.41%25M	124.53%119M	93.75%31M	116.67%39M	120.00%22M
Net income attributable to the company	-70.36%321M	-32.13%3.19B	-101.48%-18M	-22.98%945M	-2.31%1.18B	2.75%1.08B	66.82%4.71B	-13.17%1.21B	96.63%1.23B	260.71%1.21B
Preferred stock dividends
Other under preferred stock dividend	0	0	0	0	0	0	0	0	0	0
Net income attributable to common stockholders	-70.36%321M	-32.13%3.19B	-101.48%-18M	-22.98%945M	-2.31%1.18B	2.75%1.08B	66.82%4.71B	-13.17%1.21B	96.63%1.23B	260.71%1.21B
Gross dividend payment
Basic earnings per share	-70.30%9.73	-29.93%96.53	-101.51%-0.55	-21.52%28.55	1.02%35.77	10.98%32.76	81.01%137.77	-3.39%36.46	116.42%36.38	291.27%35.41
Diluted earnings per share	-70.30%9.73	-29.93%96.53	-101.51%-0.55	-21.53%28.5467	1.01%35.7688	10.98%32.76	81.01%137.77	-3.39%36.46	116.56%36.38	291.27%35.41
Dividend per share	0	-29.71%48.5	-45.00%22	0	-8.62%26.5	0	15.97%69	9.59%40	0	26.09%29
Currency Unit	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY
Accounting Standards	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP

Symbol Price % Chg

D. Western Therapeutics Institute

See the daily top gainer.